Back

Clinical relevance of impaired physiological assessment after percutaneous coronary intervention: a meta-analysis

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Intravascular imaging / physiology: guiding PCI to improve outcomes Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Robert-Jan Matthijs van Geuns

University Medical Centre St Radboud (UMCN), Nijmegen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Changes in high-sensitivity troponin according to optical characteristics of neointima and treatment modality of in-stent restenosis
Doctor N. Nano (Munich, DE)
Abstract Slides
Presentation thumbnail
Side effects and major adverse cardiac events caused by fractional flow reserve measurement: a systematic review and meta-analysis of 12,215 patients
Mr J. Altstidl (Erlangen, DE)
Abstract Slides
Presentation thumbnail
Correlation of FFR measured after DES implantation with clinical parameters and long-term clinical outcome
Doctor B. Csanadi (Budapest, HU)
Abstract Slides
Presentation thumbnail
Angiographic derived physiological assessment after intervention for predicting 2-year vessel-oriented composite endpoints in Multivessel TALENT trial
Doctor S. KAGEYAMA (Shizuoka, JP)
Abstract Slides
Presentation thumbnail
Pathological analysis of struts coverage after second- and third-generation drug-eluting stents implantation for duration of dual anti-platelets therapy; an autopsy study
Mr K. Aihara (Kanagawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Intravascular imaging / physiology: guiding PCI to improve outcomes

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Nuclear cardiology is best for risk assessment
thumbnail
Congress Presentation
Intracoronary imaging: from research tool to class IA in the Guidelines
thumbnail
Congress Presentation
Beyond the stenosis: physiological assessment in modern coronary artery disease management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources